Caris Life Sciences Inc
CAI28.290USD
+0.770+2.80%
Market hours （ET）Quotes delayed by 15 min
7.86BMarket Cap
LossP/E TTM
More Details of Caris Life Sciences Inc Company
Caris Life Sciences Inc. is a patient-centric, next-generation artificial intelligence tech bio company and precision medicine provider. The Company develops and commercializes solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale. Its entire portfolio of precision medicine solutions is designed to benefit patients, with an initial focus on oncology, and serves the clinical, academic, and biopharma markets. Its platform is purpose-built to leverage the convergence of next-generation sequencing (NGS), artificial intelligence (AI) and machine learning (ML) technologies, and high-performance computing. Its purpose-built, proprietary multi-omic profiling solutions capture and analyze molecular information from tissue and blood in a comprehensive manner. Its services for biopharma companies include prospective and retrospective profiling services, and companion diagnostics development.
Company Info
Ticker SymbolCAI
Company nameCaris Life Sciences Inc
IPO dateJun 18, 2025
Founded at2020
CEOMr. David Dean Halbert
Number of employees- -
Security typeOrdinary Share
Fiscal year-endJun 18
Address750 West John Carpenter Freeway
CityIRVING
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code75039
Phone18667718946
Websitehttps://www.carislifesciences.com/
Ticker SymbolCAI
IPO dateJun 18, 2025
Founded at2020
Company Executives
Name
Name/Position
Position
Shareholding
Change
Dr. George H. Poste, Ph.D.
Dr. George H. Poste, Ph.D.
Vice Chairman of the Board
Vice Chairman of the Board
526.22K
--
Mr. Luke Power
Mr. Luke Power
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
99.57K
--
Mr. David (Dave) Fredrickson
Mr. David (Dave) Fredrickson
Independent Director
Independent Director
16.13K
--
Vijay Mohan
Vijay Mohan
Independent Director
Independent Director
--
--
Mr. Peter M. Castleman
Mr. Peter M. Castleman
Lead Independent Director
Lead Independent Director
--
--
J. Russel Denton
J. Russel Denton
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
--
--
Dr. Jeffrey L. (Jeff) Vacirca, M.D.
Dr. Jeffrey L. (Jeff) Vacirca, M.D.
Independent Director
Independent Director
--
--
Dr. David Spetzler, Ph.D.
Dr. David Spetzler, Ph.D.
President
President
--
--
Nathan Burns
Nathan Burns
Independent Director
Independent Director
--
--
Ms. Laura I. Johansen
Ms. Laura I. Johansen
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. George H. Poste, Ph.D.
Dr. George H. Poste, Ph.D.
Vice Chairman of the Board
Vice Chairman of the Board
526.22K
--
Mr. Luke Power
Mr. Luke Power
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
99.57K
--
Mr. David (Dave) Fredrickson
Mr. David (Dave) Fredrickson
Independent Director
Independent Director
16.13K
--
Vijay Mohan
Vijay Mohan
Independent Director
Independent Director
--
--
Mr. Peter M. Castleman
Mr. Peter M. Castleman
Lead Independent Director
Lead Independent Director
--
--
J. Russel Denton
J. Russel Denton
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
--
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholding Stats
Updated: Mon, Jul 28
Updated: Mon, Jul 28
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Halbert (David D)
44.22%
Sixth Street Partners, LLC
8.34%
J.H. Whitney Capital Partners, LLC
7.29%
Castleman Peter M
3.73%
Millennium Management LLC
1.29%
Other
35.13%
Shareholders
Shareholders
Proportion
Halbert (David D)
44.22%
Sixth Street Partners, LLC
8.34%
J.H. Whitney Capital Partners, LLC
7.29%
Castleman Peter M
3.73%
Millennium Management LLC
1.29%
Other
35.13%
Shareholder Types
Shareholders
Proportion
Individual Investor
49.04%
Investment Advisor
10.07%
Private Equity
7.29%
Hedge Fund
1.29%
Investment Advisor/Hedge Fund
0.51%
Other
31.81%
Institutional Shareholding
Updated: Wed, Jul 2
Updated: Wed, Jul 2
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
18
185.77M
66.84%
+183.22M
2025Q2
18
185.77M
66.84%
+183.22M
2025Q1
3
2.55M
0.92%
+2.55M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Halbert (David D)
122.91M
44.22%
+120.52M
+5055.47%
Jun 18, 2025
Sixth Street Partners, LLC
25.64M
9.22%
+25.64M
--
Jun 18, 2025
J.H. Whitney Capital Partners, LLC
20.26M
7.29%
+20.26M
--
Jun 18, 2025
Castleman Peter M
10.37M
3.73%
+10.34M
+32049.87%
Jun 18, 2025
Millennium Management LLC
3.58M
1.29%
+3.58M
--
Jun 17, 2025
Halbert (Jon S.)
1.35M
0.49%
+1.22M
+920.73%
Jun 18, 2025
Poste (George H)
526.22K
0.19%
+526.22K
--
Jun 18, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
